Did you know some DePuy Hip Replacement Devices could be defective and lead to excess surgeries? Here’s what you need to know about this product defect.
Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?
This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn. Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]
On September 20, the Honorable David Katz presiding over the DePuy bellwether case, Ann McCracken v. DePuy Orthopaedics, Inc., et. al., Case No. 11 dp 20485, continued the trial 90 days from September 24, 2013 “in the interest of justice”. According to the Order, the Judge continued the trial so that the parties could complete [...]
Johnson & Johnson (J&J) is no stranger to controversy. From being embroiled in massive litigation in DePuy ASR artificial hips, Pinnacle litigation, and in the transvaginal mesh litigation with its Ethicon Gynecare products to its multiple legal troubles and fines associated with the anti-psychotic drug Risperdal, some things do not change for J&J – they [...]
Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011. According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]
Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?
Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures. Currently there are over 10,000 pending cases in the [...]
Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its antipsychotic drug Risperdal. The drug was approved in 1993 for use in adults and was also later [...]
Medical Device Reporting for People Injured by Vaginal Mesh, Actos, Fosamax, and DePuy ASRs: What the Consumer Needs to Know
Manufacturers, user facilities and importers of medical devices are mandated to submit certain adverse events to the U.S. Food and Drug Administration [FDA]. Medical device reporting requires that manufacturers report to the FDA when they learn that one of their devices may have contributed to a death or serious injury. Consumers and health professionals can [...]